← Back to Search

Antibiotics for Appendicitis

N/A
Recruiting
Led By Rafael Torres Fajardo, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 30
Awards & highlights
No Placebo-Only Group

Summary

This trial shows short-course antibiotics are safe, effective, and feasible for treating appendicitis.

Who is the study for?
This trial is for adults over 18 who need an appendectomy and can consent to the study. They must have a way to be contacted post-surgery. It's not for prisoners, those with weakened immune systems, allergies to Bupivacaine, suspected sepsis, uncontrolled diabetes or heart failure, pregnant women, or anyone on antibiotics for other reasons.
What is being tested?
The CASA RELAX trial is testing if short-course antibiotic treatment after surgery for simple and complicated appendicitis is safe and effective compared to longer treatments.
What are the potential side effects?
Potential side effects from the antibiotics may include allergic reactions, gastrointestinal issues like diarrhea or nausea, possible yeast infections due to disruption of normal body flora, and rarely more serious effects such as organ inflammation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 30
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 30 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants with no antibiotic related adverse effects
Secondary study objectives
Incidence of Infectious/Antibiotic Complications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Restricted Post-Operative Antibiotics GroupExperimental Treatment1 Intervention
Participants undergoing standard of care (SOC) with simple appendicitis will not receive post-operative antibiotics. Participants undergoing standard of care (SOC) with complicated (gangrenous or perforated) appendicitis will receive 24 hours of SOC post-operative antibiotics.
Group II: Restricted Duration of SOC Antibiotic UseExperimental Treatment1 Intervention
Use of Standard of Care Antibiotics, type as determined by the clinician, will be restricted to none or 24 hours of post-operatively.
Group III: Liberal Duration of SOC Antibiotic UseExperimental Treatment1 Intervention
Use of Standard of Care Antibiotics, type as determined by the clinician, will be permitted for 24 hours or 4 days of post-operatively.
Group IV: Liberal Post-Operative Antibiotics GroupActive Control1 Intervention
Participants undergoing standard of care (SOC) with simple appendicitis will receive 24 hours of post-operative antibiotics. Participants undergoing standard of care (SOC) with complicated (gangrenous or perforated) appendicitis will receive 4 days of SOC post-operative antibiotics.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,395 Previous Clinical Trials
2,459,805 Total Patients Enrolled
Rafael Torres Fajardo, MDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Restricted Post-Operative Antibiotics Group Clinical Trial Eligibility Overview. Trial Name: NCT05746520 — N/A
Appendectomy Research Study Groups: Restricted Post-Operative Antibiotics Group, Restricted Duration of SOC Antibiotic Use, Liberal Post-Operative Antibiotics Group, Liberal Duration of SOC Antibiotic Use
Appendectomy Clinical Trial 2023: Restricted Post-Operative Antibiotics Group Highlights & Side Effects. Trial Name: NCT05746520 — N/A
Restricted Post-Operative Antibiotics Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05746520 — N/A
~124 spots leftby Sep 2025